Analystreport

Ocular Therapeutix Inc (NASDAQ: OCUL) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating.

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com